Gone quiet · last update Oct 7, 2026 / Texas
The fight over the abortion pill: mifepristone access and doctors who mail it
Overview · reviewed October 28, 2026
Mifepristone, one of the two drugs used in medication abortion, the most common method of abortion in the US, has been at the center of a legal and political fight in the years since the Supreme Court overturned the nationwide right to abortion.[1][2][3] The Supreme Court rejected a challenge to the drug's approval in 2024 and in May 2026 kept access by telemedicine and mail in place after an appeals court blocked it.[3][4] States with abortion bans are now pursuing doctors in shield-law states who mail the pills, and in the fall of 2026 three of them asked the Supreme Court to strike down those shield laws.[5][6][7] The Food and Drug Administration says its own safety review of the drug will continue into 2027.[8]
The Supreme Court rejected a challenge to the drug's approval in 2024 and in May 2026 kept access by telemedicine and mail in place after an appeals court blocked it.[3][4] States with abortion bans are now pursuing doctors in shield-law states who mail the pills, and in the fall of 2026 three of them asked the Supreme Court to strike down those shield laws.[5][6][7] The Food and Drug Administration says its own safety review of the drug will continue into 2027.[8]
Coverage over time
LeftCenterRight
Weekly counts, outlets and reports (45 weeks with coverage)
| Week of (UTC) | Left | Center | Right | Of tracked | Share | Receipts |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | 7 | 9 | 4 | 20 | 4% | |
| Sep 28, 2026 | 8 | 9 | 7 | 24 | 5% | |
| Aug 10, 2026 | 3 | 0 | 2 | 5 | 1% | |
| May 11, 2026 | 20 | 23 | 9 | 52 | 30% | |
| May 4, 2026 | 18 | 14 | 8 | 40 | 23% | |
| Apr 27, 2026 | 12 | 9 | 8 | 29 | 18% | |
| Mar 9, 2026 | 0 | 0 | 6 | 6 | 4% | |
| Feb 2, 2026 | 2 | 2 | 0 | 4 | 2% | |
| Jan 12, 2026 | 4 | 2 | 1 | 7 | 4% | |
| Sep 29, 2025 | 11 | 21 | 10 | 42 | 21% | |
| Sep 1, 2025 | 7 | 9 | 2 | 18 | 10% | |
| Feb 10, 2025 | 4 | 9 | 1 | 14 | 7% | |
| Feb 3, 2025 | 2 | 2 | 2 | 6 | 3% | |
| Jan 27, 2025 | 8 | 8 | 5 | 21 | 9% | |
| Jan 13, 2025 | 6 | 15 | 3 | 24 | 11% | |
| Dec 16, 2024 | 0 | 1 | 2 | 3 | 1% | |
| Dec 9, 2024 | 11 | 12 | 4 | 27 | 13% | |
| Nov 4, 2024 | 3 | 2 | 5 | 10 | 4% | |
| Sep 30, 2024 | 2 | 7 | 1 | 10 | 5% | |
| Jun 10, 2024 | 45 | 44 | 19 | 108 | 44% | |
| May 20, 2024 | 13 | 21 | 12 | 46 | 20% | |
| May 13, 2024 | 4 | 8 | 5 | 17 | 8% | |
| Apr 29, 2024 | 0 | 5 | 3 | 8 | 3% | |
| Mar 25, 2024 | 32 | 45 | 13 | 90 | 37% | |
| Mar 18, 2024 | 6 | 6 | 4 | 16 | 7% | |
| Feb 26, 2024 | 18 | 16 | 6 | 40 | 16% | |
| Feb 5, 2024 | 1 | 5 | 1 | 7 | 3% | |
| Jan 29, 2024 | 2 | 1 | 4 | 7 | 3% | |
| Dec 11, 2023 | 25 | 29 | 21 | 75 | 33% | |
| Sep 4, 2023 | 6 | 9 | 4 | 19 | 8% | |
| Aug 21, 2023 | 1 | 3 | 4 | 8 | 3% | |
| Aug 14, 2023 | 14 | 17 | 12 | 43 | 17% | |
| May 8, 2023 | 2 | 5 | 3 | 10 | 4% | |
| Apr 24, 2023 | 3 | 5 | 0 | 8 | 3% | |
| Apr 17, 2023 | 45 | 49 | 22 | 116 | 46% | |
| Apr 10, 2023 | 49 | 44 | 22 | 115 | 45% | |
| Apr 3, 2023 | 31 | 37 | 17 | 85 | 33% | |
| Mar 13, 2023 | 18 | 24 | 7 | 49 | 27% | |
| Mar 6, 2023 | 0 | 1 | 0 | 1 | 1% | |
| Feb 6, 2023 | 6 | 18 | 7 | 31 | 17% | |
| Jan 2, 2023 | 22 | 25 | 19 | 66 | 35% | |
| Nov 14, 2022 | 2 | 1 | 5 | 8 | 4% | |
| Feb 21, 2022 | 2 | 6 | 0 | 8 | 4% | |
| Dec 13, 2021 | 11 | 20 | 10 | 41 | 21% | |
| Nov 29, 2021 | 1 | 3 | 0 | 4 | 2% |
Latest coverage
Background
In December 2021, the Food and Drug Administration permanently dropped its requirement that mifepristone be picked up in person,[9] the same month a Texas law limiting access to abortion pills took effect.[10] In January 2023 the FDA finalized a rule letting certified retail and mail-order pharmacies dispense the drug.[11][12] By then anti-abortion groups had sued to reverse the FDA's approval of mifepristone, first granted in 2000.[13][14] On April 7, 2023, a federal judge in Texas ruled the approval improper, while a federal judge in Washington state ordered the FDA to keep the drug available in 17 states.[15][16] The Justice Department appealed,[17] an appeals court kept the pill available with restrictions,[18] and the Supreme Court froze the lower-court rulings while the case continued.[19]
Read the full background (3 more paragraphs)
The case, brought by the Alliance for Hippocratic Medicine, reached the Supreme Court after the Fifth Circuit appeals court ruled to restrict the drug in August 2023.[20][21] Before the argument, a publisher retracted studies the Texas judge had relied on.[22] On June 13, 2024, the court unanimously rejected the challenge, ruling that the anti-abortion doctors who brought it lacked standing to sue.[3] Walgreens and CVS began selling the drug in some states,[23] and a survey found that about 8,000 women a month were getting abortion pills despite their states' bans or restrictions, often through telehealth.[24] Louisiana became the first state to classify mifepristone and misoprostol as controlled dangerous substances.[25][26]
With Donald Trump's return, the fight moved to doctors who prescribe the pills across state lines under shield laws meant to protect them. Texas Attorney General Ken Paxton sued a New York doctor for mailing pills to Texas,[27] and a Texas judge fined her more than $100,000;[28] a Louisiana a New York doctor, Margaret Carpenter, on charges of prescribing pills to a pregnant minor, and New York Gov. Kathy Hochul signed a law to shield prescribers' identities.[5][29] Texas passed a law letting residents sue out-of-state pill providers,[30] and a California doctor became the first sued under it.[6] Gov. Gavin Newsom refused Louisiana's request to extradite a California doctor it had charged with mailing pills.[31][32] Meanwhile three states pressed a new suit before the same Texas judge,[33] the FDA approved a new generic version of the drug, angering conservatives,[34] and Republican Sen. Josh Hawley introduced a bill to withdraw its approval.[35]
In May 2026 an appeals court temporarily blocked the federal rule allowing mifepristone to be dispensed by mail,[36] and after a short stay signed by Justice Samuel Alito, the Supreme Court kept telemedicine and mail access in place.[37][4] Anti-abortion groups then urged Attorney General Todd Blanche to stop the mailing of abortion pills,[38] three states with near-total bans asked the Supreme Court to strike down shield laws,[7] and the FDA said its safety review of the drug would run into next year, a timeline abortion opponents quickly condemned.[8]
Supporting stories (38)
- What is mifepristone, the drug at the heart of the Texas medication abortion lawsuit?
- Court schedules abortion pill case for March argument session
- Supreme Court upholds broad access to key abortion pill Mifepristone
- Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
- New York doctor indicted for prescribing abortion pill in Louisiana
- California doctor sued for allegedly providing abortion pill to Texas patient
- Republican AGs sue abortion ‘shield law’ states in US Supreme Court
- FDA says its safety review of abortion pill will continue into next year
- Abortion pills by mail to be allowed as US health regulators permanently loosen restrictions
- As Roe hangs in the balance, new Texas law restricts use of abortion-inducing medicine
- FDA to allow pharmacies to dispense abortion pills to patients
- Now able to sell abortion pill, U.S. pharmacies weigh if they should
- Conservative group sues FDA to revoke approval of abortion pill
- Texas Lawsuit Could Pull Abortion Pill Off the Market Nationwide
- US appeals court preserves access to abortion pill but tightens rules
- Judge in Washington orders feds to keep abortion pill access, countering ruling by Texas judge
- Justice Department appeals Texas court ruling to halt order of commonly used abortion pill
- Abortion opponents urge Supreme Court to allow limits on abortion drug
- Supreme Court Preserves Access to Abortion Pill, for Now: What's Next?
- Appeals court wants limits on abortion pill access, sending case to Supreme Court
- Justice Department asks Supreme Court to end abortion pill legal challenge that threatens widespread access
- Studies cited in case over abortion pill are retracted due to flaws and conflicts of interest
- Walgreens, CVS to start selling abortion pill in store
- Survey finds 8,000 women a month got abortion pills despite their states' bans or restrictions
- Louisiana governor signs bill to classify abortion pills as controlled substances into law
- A new Louisiana law requires abortion meds to be locked in a cabinet, even if needed for emergency care
- Ken Paxton sues New York doctor accused of prescribing abortion pills to Texas woman
- Texas judge fines New York doctor for prescribing abortion pills to a woman near Dallas
- New York adds protections for doctors who send abortion pills out of state
- Texas lawmakers approve letting private citizens sue abortion pill providers
- Louisiana seeks arrest of California doctor accused of mailing abortion pills
- Newsom moves to stop Louisiana from extraditing doctor accused of mailing abortion pills
- Texas judge says states can revive challenge to abortion pill access nationwide
- FDA approves another generic abortion pill, prompting outrage from conservatives
- Hawley rolls out bill to nix FDA approval for mifepristone, used for almost two-thirds of US abortions
- Federal appeals court restricts abortion access by temporarily blocking the mailing of mifepristone
- Supreme Court restores access to abortion pill mifepristone through telehealth, mail and pharmacies
- Anti-abortion groups urge AG to halt mailing of abortion pills
The full record
May 2026
April 2026
January 2026
September 2025
February 2025
January 2025
September 2024
May 2024
- Louisiana House passes bill that would classify abortion drugs as controlled dangerous substances
- Louisiana governor signs bill to classify abortion pills as controlled substances into law
- Survey finds 8,000 women a month got abortion pills despite their states' bans or restrictions
- Louisiana bill would classify abortion drugs as controlled dangerous substances
March 2024
February 2024
September 2023
August 2023
April 2023
- Canada could supply US with abortion pills if courts ban it, official says
- Generic abortion pill maker GenBioPro sues FDA over its response to orders halting drug's approval
- Supreme Court Preserves Access to Abortion Pill, for Now: What's Next?
- US Supreme Court's abortion pill order spares safe havens
- Abortion opponents urge Supreme Court to allow limits on abortion drug
- Some US states stock abortion medications after court ruling
- Supreme Court temporarily keeps FDA abortion pill rules in place
- US appeals court preserves access to abortion pill but tightens rules
- Justice Department appeals Texas court ruling to halt order of commonly used abortion pill
- AOC urges Biden to ignore Texas ruling suspending approval of abortion drug
- Can the FDA just ignore the Texas judge's abortion pill ban?
- Justice Dept. asks court to further delay abortion medication decision
- Judge in Washington orders feds to keep abortion pill access, countering ruling by Texas judge
- House Democrats to introduce bill to shore up abortion pill access after Texas ruling
March 2023
January 2023
Coverage & sources
Read the reports, see how much was collected over time, or compare outlets by political leaning.